Contact and Address
| Category: | Health, |
|---|---|
| Address: | 91 Hartwell Ave, Lexington, MA 02421, USA |
| Postal code: | 02421 |
| Phone: | (781) 676-2100 |
| Website: | http://www.inotekcorp.com/ |
Hours:
| Monday: | 9:00 AM – 5:00 PM |
|---|---|
| Tuesday: | 9:00 AM – 5:00 PM |
| Wednesday: | 9:00 AM – 5:00 PM |
| Thursday: | 9:00 AM – 5:00 PM |
| Friday: | 9:00 AM – 5:00 PM |
| Saturday: | Closed |
| Sunday: | Closed |
Location & routing
Most Recent Reviews
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Inotek Pharmaceuticals, use the form below and your opinion, advice or comment will appear in this space.
Photos of Inotek Pharmaceuticals
Inotek Pharmaceuticals On the Web
Inotek Pharmaceuticals Corporation: Private Company ...
781-676-2100. Key Executives for Inotek Pharmaceuticals Corporation. ... To contact Inotek Pharmaceuticals Corporation, please visit --. Company data is provided by S&P Global Market Intelligence ...
Inotek Pharmaceuticals - MarketWatch.com
Biotech developing a small molecule eye drop therapy to treat glaucoma. Filing Information. File Date. 11/5/2014
Inotek Pharmaceuticals - lawinsider.com
View 78 Inotek Pharmaceuticals contracts and agreements from SEC filings. Including company executives, business partners, clauses and more. ... 781-676-2100 ...
INOTEK PHARMACEUTICALS CORP (Form: S-1/A, Received: 02/17 ...
INOTEK PHARMACEUTICALS CORPORATION (Exact Name of Registrant as Specified in Its Charter) ... (781) 676-2100 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent ...
Inotek Pharmaceuticals Corporation - IPO Candy
Inotek Pharmaceuticals Corporation was founded in 1999 and is headquartered in Lexington, Massachusetts.</p> ... //www.inotekcorp.com 781-676-2100 Address. 131 ...
Follow the Money: Inotek Pharmaceuticals | PharmSource
Inotek Pharmaceuticals is a U.S. public pharmaceutical company that develops therapies with novel mechanisms of action to address significant diseases of the eye. As reported in the February 26, 2015 issue of the PharmSource Lead Sheet, Inotek raised $40 million in the closing of an initial public offering.
Inotek Pharmaceuticals Corporation to Present at the Cowen ...
Inotek Pharmaceuticals (781) 676-2100 Media Relations: Sarah Cavanaugh MacDougall Biomedical Communications Email Contact (781) 235-3060 . Digg this Bookmark with del ...
Scientific Advisory Board - Inotek Pharmaceuticals
After 32 years of service as Chair, Dr. Laties continues to serve as a Vice Chair of the Scientific Advisory Board of the Foundation Fighting Blindness. Currently he is the Harold G. Scheie-Nina C. Mackall Research Professor of Ophthalmology at the University of Pennsylvania Medical School.
Inotek Pharmaceuticals' Novel Glaucoma Candidate, INO-8875 ...
Inotek Pharmaceuticals Adam L. Muzikant, Ph.D., 781-676-2100 Senior Director, Business Development or Media Relations: MacDougall Biomedical Communications Sarah Cavanaugh, 781-235-3060 scavanaugh ...